McInnes Wilson has advised the Mediquip Group on four separate bolt-on acquisitions in the past 12 months.
About Mediquip
Mediquip is a leading provider of innovative biomedical equipment and services to healthcare, veterinary and dental industries.
The Brisbane-headquartered business, which is majority owned by a domestic Australian growth equity investment firm, has expanded through organic growth and acquisitions to become an Australia-wide diversified medical company, driven by technological advantage.
About the bolt-on acquisitions
In the last 12 months, McInnes Wilson has advised the Mediquip Group on four separate bolt-on acquisitions:
- 1(AustVet Endoscopy) a Victorian based distribution business, specialising in a wide range of rigid and flexible endoscopy equipment and instruments for small animal and equine applications;
- 2(Bosco Medical) a Queensland based medical distribution business, specialising in life sustaining products and equipment within the Australian healthcare industry;
- 3(Innovative Medical Solutions) a Western Australian distribution business, specialising in the supply and servicing of electrograph, patient monitoring, ultrasound, vascular and veterinary equipment; and
- 4(James Optronics) a Western Australian distributor with exclusive supply rights for the supply of surgical microscopes in certain jurisdictions across Australia, which trades as L.M.G. Scientific Services.
The transactions contribute to the ongoing growth of Mediquip’s expertise in distribution and servicing for the medical and veterinary industries.
Work provided by McInnes Wilson
McInnes Wilson advised the Mediquip Group on all legal matters affecting each of the transactions, including:
- 1buy-side legal due diligence on each of the targets;
- 2preparation and negotiation of the principal asset and share sale agreements (which, on some occasions, included bespoke earn out and deferred consideration concepts);
- 3preparation and negotiation of a number of ancillary transaction documents (including key staff agreements and post-completion service agreements);
- 4specialist duty advice on some of the transactions (including apportionment advice based on the location of each business’ operations and customers);
- 5advice on regulatory matters, including the requisite approvals with the Foreign Investment Review Board and the Therapeutic Goods Administration;
- 6industrial relations advice on employee agreements with key personnel; and
- 7various completion matters.
The Corporate and Commercial Advisory team was led by Nick Camphin and Chris Davis, who were assisted by Nick Wilson and Christopher Fox.
The Corporate and Commercial Advisory team were assisted by other teams in the Brisbane, Melbourne and Sydney offices, including Property and Projects (led by Matthew Russell) and Industrial Relations (led by Ryan Murphy).
GET IN TOUCH WITH US!
Principal
Principal
Senior Associate
Solicitor
